212 related articles for article (PubMed ID: 20865844)
1. Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice.
Cerio R; Dohil M; Jeanine D; Magina S; Mahé E; Stratigos AJ
J Drugs Dermatol; 2010 Sep; 9(9):1116-20. PubMed ID: 20865844
[TBL] [Abstract][Full Text] [Related]
2. Colloidal oatmeal: history, chemistry and clinical properties.
Kurtz ES; Wallo W
J Drugs Dermatol; 2007 Feb; 6(2):167-70. PubMed ID: 17373175
[TBL] [Abstract][Full Text] [Related]
3. Oatmeal in dermatology: a brief review.
Pazyar N; Yaghoobi R; Kazerouni A; Feily A
Indian J Dermatol Venereol Leprol; 2012; 78(2):142-5. PubMed ID: 22421643
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin.
Reynertson KA; Garay M; Nebus J; Chon S; Kaur S; Mahmood K; Kizoulis M; Southall MD
J Drugs Dermatol; 2015 Jan; 14(1):43-8. PubMed ID: 25607907
[TBL] [Abstract][Full Text] [Related]
5. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis.
Fowler JF; Nebus J; Wallo W; Eichenfield LF
J Drugs Dermatol; 2012 Jul; 11(7):804-7. PubMed ID: 22777219
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory ingredients.
Wu J
J Drugs Dermatol; 2008 Jul; 7(7 Suppl):s13-6. PubMed ID: 18681154
[TBL] [Abstract][Full Text] [Related]
7. Innovations in natural ingredients and their use in skin care.
Fowler JF; Woolery-Lloyd H; Waldorf H; Saini R
J Drugs Dermatol; 2010 Jun; 9(6 Suppl):S72-81; quiz s82-3. PubMed ID: 20626172
[TBL] [Abstract][Full Text] [Related]
8. Colloidal Oatmeal (Avena Sativa) Improves Skin Barrier Through Multi-Therapy Activity.
Ilnytska O; Kaur S; Chon S; Reynertson KA; Nebus J; Garay M; Mahmood K; Southall MD
J Drugs Dermatol; 2016 Jun; 15(6):684-90. PubMed ID: 27272074
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the allergic contact dermatitis potential of colloidal grain suspensions.
Pigatto P; Bigardi A; Caputo R; Angelini G; Foti C; Grandolfo M; Rizer RL
Am J Contact Dermat; 1997 Dec; 8(4):207-9. PubMed ID: 9358111
[TBL] [Abstract][Full Text] [Related]
10. Colloidal oatmeal formulations and the treatment of atopic dermatitis.
Fowler JF
J Drugs Dermatol; 2014 Oct; 13(10):1180-3; quiz 1184-5. PubMed ID: 25607551
[TBL] [Abstract][Full Text] [Related]
11. ARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis.
Allais B; Friedman A
J Drugs Dermatol; 2020 Oct; 19(10):s4-s7. PubMed ID: 33026768
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled clinical study to evaluate the effectiveness of an active moisturizing lotion with colloidal oatmeal skin protectant versus its vehicle for the relief of xerosis.
Kalaaji AN; Wallo W
J Drugs Dermatol; 2014 Oct; 13(10):1265-8. PubMed ID: 25607563
[TBL] [Abstract][Full Text] [Related]
13. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
14. ARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema.
Allais B; Friedman A
J Drugs Dermatol; 2020 Oct; 19(10):s8-s11. PubMed ID: 33026769
[TBL] [Abstract][Full Text] [Related]
15. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of topical therapies and the rationale for combination therapy.
Norris DA
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260
[TBL] [Abstract][Full Text] [Related]
17. Natural ingredients in atopic dermatitis and other inflammatory skin disease.
Dohil MA
J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s128-32. PubMed ID: 24002161
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
19. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
Bornhövd E; Burgdorf WH; Wollenberg A
J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
[TBL] [Abstract][Full Text] [Related]
20. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
